Exicure Inc
XCUR4.100USD
-0.130-3.07%
終値 11/05, 16:00（ET）15分遅れの株価
25.90M時価総額
損失額直近12ヶ月PER
詳細情報 Exicure Inc 企業名
Exicure, Inc. is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The Company, through GPCR Therapeutics USA Inc. (GPCR USA), is focused on developing and commercializing an intellectual property and patents related to G-Protein Coupled Receptors. GPCR USA is conducting a Phase II clinical trial for a blood cancer treatment involving GPC-100 (Burixafor). The Company is also exploring strategic alternatives to maximize stockholder value.
Exicure Incの企業情報
企業コードXCUR
会社名Exicure Inc
上場日May 09, 2018
最高経営責任者「CEO」Mr. Paul Kang
従業員数7
証券種類Ordinary Share
決算期末May 09
本社所在地2430 N. Halsted St.
都市CHICAGO
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号60614
電話番号18476731707
ウェブサイトhttps://www.exicuretx.com/
企業コードXCUR
上場日May 09, 2018
最高経営責任者「CEO」Mr. Paul Kang
Exicure Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
President, Chief Scientific Officer
President, Chief Scientific Officer
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Josephine (Pina) Cardarelli, Ph.D.
Dr. Josephine (Pina) Cardarelli, Ph.D.
President, Chief Scientific Officer
President, Chief Scientific Officer
--
--
Mr. Sangjn Yeo
Mr. Sangjn Yeo
Independent Director
Independent Director
--
--
Ms. Aejin Hwang
Ms. Aejin Hwang
Independent Director
Independent Director
--
--
Mr. Andy Yoo
Mr. Andy Yoo
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Seung Ik Baik
Mr. Seung Ik Baik
Chief Financial Officer, Secretary, Director
Chief Financial Officer, Secretary, Director
--
--
Mr. Dongho Lee
Mr. Dongho Lee
Independent Director
Independent Director
--
--
収益内訳
データなし
データなし
事業別
地域別
データなし
株主
更新時刻: Fri, Aug 29
更新時刻: Fri, Aug 29
株主統計
種類
株主統計
株主統計
比率
Exicure Hitron Inc. Employees
52.76%
DGP Co., Ltd.
7.80%
Sangsangin Investment & Securities Co. Ltd.
6.86%
Abingworth Management Limited
4.46%
CBI USA, Inc.
2.59%
他の
25.53%
株主統計
株主統計
比率
Exicure Hitron Inc. Employees
52.76%
DGP Co., Ltd.
7.80%
Sangsangin Investment & Securities Co. Ltd.
6.86%
Abingworth Management Limited
4.46%
CBI USA, Inc.
2.59%
他の
25.53%
種類
株主統計
比率
Corporation
63.15%
Research Firm
6.87%
Venture Capital
4.46%
Investment Advisor
0.90%
Investment Advisor/Hedge Fund
0.31%
Hedge Fund
0.18%
Endowment Fund
0.17%
他の
23.97%
機関投資家保有株
更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
34
813.94K
12.88%
+414.48K
2025Q2
39
5.19M
82.14%
+459.49K
2025Q1
39
5.11M
80.94%
+626.75K
2024Q4
39
2.19M
79.53%
+1.26M
2024Q3
38
1.16M
47.48%
+231.16K
2024Q2
41
935.92K
56.32%
-7.21K
2024Q1
63
954.65K
57.41%
-102.69K
2023Q4
69
1.01M
60.85%
-61.54K
2023Q3
83
1.06M
66.48%
-70.11K
2023Q2
96
1.06M
66.44%
-83.25K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Exicure Hitron Inc. Employees
3.33M
52.76%
--
--
Sep 18, 2025
DGP Co., Ltd.
492.61K
7.8%
--
--
Sep 09, 2025
Sangsangin Investment & Securities Co. Ltd.
433.33K
6.86%
+433.33K
--
Dec 12, 2024
Abingworth Management Limited
281.64K
4.46%
--
--
Jun 30, 2025
CBI USA, Inc.
163.66K
2.59%
--
--
Sep 12, 2024
The Vanguard Group, Inc.
27.84K
0.44%
+8.81K
+46.27%
Jun 30, 2025
UBS Financial Services, Inc.
26.27K
0.42%
+25.70K
+4540.99%
Jun 30, 2025
Geode Capital Management, L.L.C.
18.96K
0.3%
-135.00
-0.71%
Jun 30, 2025
Millennium Management LLC
10.66K
0.17%
+10.66K
--
Jun 30, 2025
Northwestern University
10.43K
0.17%
--
--
Jun 30, 2025
詳細を見る
関連ETF
更新時刻: Sun, Nov 2
更新時刻: Sun, Nov 2
銘柄名
比率
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
比率0%
iShares Core S&P Total U.S. Stock Market ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
日付
種類
比率
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Aug 26, 2024
Merger
5→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
Jun 29, 2022
Merger
30→1
